Panacea Biotec Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Panacea Biotec Limited generated cash of -$1,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$28,080,000 last year. Net change in cash is therefore $73,220,000.
Cash Flow
| 2010 | 621.70M | -1.17B | 275.59M |
|---|---|---|---|
| 2011 | 901.7M | -198.3M | -670.6M |
| 2012 | 2.28B | -1.23B | -1.33B |
| 2016 | 906.9M | 164.4M | -1.17B |
| 2018 | 1.18B | 552.94M | -1.64B |
| 2020 | -304.7M | -347.6M | 907.39M |
| 2021 | 1.06B | -476.79M | -471.1M |
| 2023 | -4.23B | 4.30B | -183.8M |
| 2024 | -1M | 102.27M | -28.08M |
PANACEABIO.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 398.52M | 503.5M | 402.18M | 144.66M | 74.68M | 199.9M | 442.6M | 362.4M | 678.04M |
Operating activities | |||||||||
Net income | -11.73M | 128M | -1.45B | -1.77B | -661.39M | -189.3M | -2.05B | 1.32B | 724.12M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 367.11M | 391.2M | 460.74M | 441.35M | 585.33M | 733.2M | 526.1M | 758.9M | 658.78M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 29.56M | 68.94M | -168.57M | 201.14M | -203.67M | -412.8M | 0 | 0 | 0 |
Inventories | 241.58M | 106.3M | -264.45M | -662.64M | -188.32M | 49.9M | 253.7M | 874.9M | -63.67M |
Accounts payable | 0 | 0 | 235.08M | -496.89M | 312.74M | -210M | 0 | 0 | 0 |
Cash generated by operating activities | -1M | -4.23B | 1.06B | -304.7M | 1.18B | 906.9M | 2.28B | 901.7M | 621.70M |
Investing activities | |||||||||
Purchases Of Investments | -3.47B | -8.67B | -391.93M | -452.93M | -38.73M | -20.7M | 0 | -300K | -4.42M |
Investments In Property Plant And Equipment | -777.18M | -409.5M | -217.63M | -69.11M | -152.16M | -113.2M | -1.34B | -499.2M | -1.22B |
Acquisitions Net | 0 | -4.20B | 55.9M | 452.21M | 723.07M | 57.3M | 0 | 0 | 0 |
Cash generated by investing activities | 102.27M | 4.30B | -476.79M | -347.6M | 552.94M | 164.4M | -1.23B | -198.3M | -1.17B |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 320M | 0 | 337.8M | 0 | 0 | 29.91M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -53.4M | -15.6M | -38.82K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.09B | 0 |
Repayments of term debt | -2.36M | -147.74M | -489.14M | 1.03B | -548.52M | -752.6M | -2.18B | -188.8M | -327.66M |
Cash used in financing activities | -28.08M | -183.8M | -471.1M | 907.39M | -1.64B | -1.17B | -1.33B | -670.6M | 275.59M |
Net Change In Cash | 73.22M | -105M | 118.61M | 257.52M | 89.69M | -102.4M | -290.9M | 31.1M | -282.23M |
Cash at end of period | 471.74M | 398.5M | 520.79M | 402.18M | 164.37M | 97.5M | 151.7M | 393.5M | 395.81M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |